J2545 Pentamidine non-comp unit

Pentamidine isethionate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 300 mg

• Medicare coverage: Special coverage instructions apply
• Status: active (July 2026 file)
• MUE: max 1 units per day (practitioner), rationale: Prescribing Information